1.A Case of Liquefied Posterior Capsular Opacification.
Joo Hwa LEE ; Chul Ho GO ; Myung Jin JOO
Journal of the Korean Ophthalmological Society 1999;40(9):2632-2635
Among the complications of cataract surgery, the reported frequency of posterior capsular opacification was 20~50 percent. We experienced a case of new type of posterior capsular opacification in the seventy-one year old woman patient, who undertook the cataract operation with phacoemulsification six years ago and visited our hospital with the decreased vision. With biomicroscopic examination, posterior capsular opacification, creating a closed chamber between the lens and the posterior capsule in which a liquefied, milky white substance accumulates was detected. The patient was treated with Nd: YAG laser capsulotomy. To our knowledge, there has been no reported case of liquefied posterior capsular opacification in Korea. Therefore we report this case with literature review.
Cataract
;
Female
;
Humans
;
Korea
;
Lasers, Solid-State
;
Phacoemulsification
2.Esophagus, Stomach & Intestine; Infiltrative Advanced Gastric Cancer Simulating Early Gastric Cancer: Case report.
Jong Chul RHEE ; Hwa Young LEE ; Poong Lyul RHEE ; Jae Jun KIM ; Seung Woon PAIK ; Young Lyun OH ; Kwang Cheul KOH
Korean Journal of Gastrointestinal Endoscopy 1997;17(2):187-194
Advanced gastric cancer simulating early gastric cancer is increasing tendcncy due to development of diagnostic technology. A 64-year-old woman was admitted for epigastric discomfort. Endoscopy showed a small white mucus coated erosion and peripheral mucosal nodurarity on greater curvature side of antrum. Biopsy was resulted in adenocarcinoma. An upper GI series and abdominal sonography were normal. At surgery, advanced gastric carcinoma, Borrmann localized type IV in background of early gastric carcinoma, prepyloric antrum along the greater curvature with infiltration to the muscle layer and multiple lymphatic tumor emboli in serosa and perigastric adipose tissue and neural invasion and metastasis to 12 out of 28 perigastric lymph nodes with extranodal extension. 3 months later, distant metastasis such as cervical lymph node, pleural effusion, pericardial effusion, peritoneal seeding and ascites were noticed.
Adenocarcinoma
;
Adipose Tissue
;
Ascites
;
Biopsy
;
Endoscopy
;
Esophagus*
;
Female
;
Humans
;
Intestines*
;
Lymph Nodes
;
Middle Aged
;
Mucus
;
Neoplasm Metastasis
;
Pericardial Effusion
;
Pleural Effusion
;
Serous Membrane
;
Stomach Neoplasms*
;
Stomach*
3.Esophagus, Stomach & Intestine; Endoscopic Findings of Gastric Mucosa: Associated Lymphoid Tissue (MALT) Lymphoma.
Jong Chul RHEE ; Hwa Young LEE ; Poong Lyul RHEE ; Jae Jun KIM ; Seung Woon PAIK ; Kwang Cheul KOH ; Jae Hyang GO
Korean Journal of Gastrointestinal Endoscopy 1997;17(2):125-132
BACKGROUND/AIMS: Helicobacter pylori is found in more than 90% of patients with gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Regression of lymphoma after H. pylori eradication was reported. Therefore, early detection of gastric MALT lymphoma is important. On reported several endoscopic findings, nonspecific gastritis with erosion and ulceration were common and there is no typical endoscopic findings. METHODS: Therefore we analyzed the endoscopic findings of 16 low-grade B-cell gastric MALT lymphoma confirmed by biopsy, PCR and immunostain and compared histologic change after eradicating H. pylori infection in patients who refused operation retrospectively from March 1995 to October 1996. RESULTS: The male: female ratio was 7:9 and mean age was 43,7 years ald (23-71 yr), On endoscopic findings of gastric MALT lymphoma, irregular shaped geographic superficial ulcer was 7 cases (43.7%), diffuse mucosal nodularity was 4 cases (25.0%) and erosion was 3 cases (18.7%). The most common site of MALT lymphoma was antrum and angle. H. pylori was positive in 87.5% (14/16 cases) and eradication of H. pylori was done in patients who refused operation and histologic improvement after H. pylori eradication was found in 62.5% (5/8 cases). CONCLUSIONS: The most common endoscopic findings of gastric MALT lymphoma was irregular geographic superficial ulcer but diffuse mucosal nodularity and erosions were also common. Therefore, biopsy must be taken, especially on the antrum and angle although nonspecific lesion may be suspected.
B-Lymphocytes
;
Biopsy
;
Endoscopy
;
Esophagus*
;
Female
;
Gastric Mucosa*
;
Gastritis
;
Helicobacter pylori
;
Humans
;
Intestines*
;
Lymphoid Tissue*
;
Lymphoma*
;
Lymphoma, B-Cell, Marginal Zone
;
Male
;
Polymerase Chain Reaction
;
Retrospective Studies
;
Stomach*
;
Ulcer
4.Bilateral hydrothorax and cardiac tamponade after right subclavian vein catheterization: A case report.
Myoung Hwa KIM ; Dong Jun LEE ; Mun Chul KIM
Korean Journal of Anesthesiology 2010;59(Suppl):S211-S217
Central venous catheterization is typically used for the anesthetic management of patients undergoing a major surgery or care of patients in Intensive Care Unit (ICU). The occurrence of complications associated with central venous catheterization such as pneumothorax or vascular injury have decreased, while delayed complications such as hydrothorax, hydromediastinum, or cardiac tamponade have risen recently. We report a case of complications of bilateral hydrothorax with cardiac tamponade by superior vena cava perforation due to continuous mechanical force of the looped central venous catheter tip against SVC wall after subclavian vein cannulation.
Cardiac Tamponade
;
Catheterization
;
Catheterization, Central Venous
;
Central Venous Catheters
;
Humans
;
Hydrothorax
;
Intensive Care Units
;
Pneumothorax
;
Subclavian Vein
;
Vascular System Injuries
;
Vena Cava, Superior
5.Bowel Ischemia by Blunt Abdominal Trauma.
Jong Chul RHEE ; Hwa Young LEE ; Kwang Cheol KOH ; Poong Lyul RHEE ; Jae Jun KIM ; Seung Woon PAIK ; Young Lyun OH
Korean Journal of Gastrointestinal Endoscopy 1996;16(4):651-657
The intestine is the third most commonly injured abdominal organ in blunt trauma. But we had a paucity of experience with these injuries. We experienced bowel ischemia in 55 year-old woman after motor-vehicle accident. She complained nausea, vomiting and weight, loss after traffic accident. We found mucosal hyperemia and intraluminal stenosis of duodenal second portion by the gastroscopy. So, we performed hypotonic duodenography and SMA and celiac angiograpby. Hypotonie duodenography showed a luminal narrowing from duodenojejunal junction to proximal jejunum and proximal dilatation, and SMA angiography showed 10 cm segment hypervascular staining of contrast medium in proximal portion. Therefore we performed jejunal loop segmentectomy. After operation she was discharged without complication.
Accidents, Traffic
;
Angiography
;
Constriction, Pathologic
;
Dilatation
;
Female
;
Gastroscopy
;
Humans
;
Hyperemia
;
Intestines
;
Ischemia*
;
Jejunum
;
Mastectomy, Segmental
;
Middle Aged
;
Nausea
;
Phenobarbital
;
Vomiting
6.Unexpected Detachment of Solitaire Stents during Mechanical Thrombectomy.
Sung Tae KIM ; Sung Chul JIN ; Hae Woong JEONG ; Jung Hwa SEO ; Sam Yeol HA ; Hae Wook PYUN
Journal of Korean Neurosurgical Society 2014;56(6):463-468
OBJECTIVE: Unexpected Solitaire stent detachment can occur during mechanical Solitaire thrombectomy. The purpose of this study was to retrospectively evaluate the influencing factors causing unexpected Solitaire stent detachment and the clinical outcomes. METHODS: Between October 2011 to December 2013, 232 cases of mechanical Solitaire thrombectomy for acute ischemic stroke were performed in 3 stroke centers. During this period, we encountered unexpected Solitaire stent detachments during mechanical Solitaire thrombectomies in 9 cases. RESULTS: Solitaire stents unexpectedly detached in 9 cases (3.9%) during the retrieval of Solitaire stents. The median patient age was 76 years. The occlusion sites of the unexpected stent detachment were the proximal middle cerebral artery (MCA) in 7 cases and the internal carotid artery in 2 cases. The sizes of the stents that unexpectedly detached were 6x30 mm in 7 cases, 5x30 mm in 1 case, and 4x20 mm in 1 case. Four patients had unexpected detachment at the first retrieval, 1 patient at the second, 3 patients at the third, and 1 patient at the fifth. In all of the cases of unexpected detachment at the first retrieval, the stent deployment site was the proximal MCA. After detachment, a proximal marker of the Solitaire stent was observed in 3 patients. However, no marker was visible in the remaining 6 patients. CONCLUSION: Unexpected Solitaire stent detachment should be considered in the first instance of stent retrieval for a relatively large-diameter stent, especially in elderly patients with MCA occlusions.
Aged
;
Carotid Artery, Internal
;
Humans
;
Middle Cerebral Artery
;
Retrospective Studies
;
Stents*
;
Stroke
;
Thrombectomy*
7.Advantages and disadvantages of the ENVOY 6F distal access guiding catheter in endovascular coiling for anterior circulation aneurysms
Jin Wook BAEK ; Sung Chul JIN ; Sung Tae KIM ; Young Jin HEO ; Ji Yeon HAN ; Jung Hwa SEO ; Sung Hwa PAENG ; Jung Soo KIM ; Hae Woong JEONG ; Young Gyun JEONG
Journal of Cerebrovascular and Endovascular Neurosurgery 2019;21(1):5-10
OBJECTIVE: Selecting an appropriate guiding catheter to provide both sufficient supportability for working devices and sufficient distal navigability is essential for ensuring the success of a procedure. This study aimed to evaluate the advantages and disadvantages of using the ENVOY 6F distal access (DA) guiding catheter in coil embolization of anterior circulation cerebral aneurysms.METHODS: We included 98 patients (72 [73.5%] women, median age: 63 [range: 25–84] years) who underwent endovascular coiling with the ENVOY 6F DA guiding catheter from May to November 2016. We analyzed data on patient demographics and the number of co-axial techniques to position the guiding catheter, initial and final location of the catheter, and complications related to the catheter.RESULTS: The co-axial technique was used to position the ENVOY 6F DA guiding catheter in the internal carotid artery (ICA) in 20 cases (20.41%). The initial position of the ENVOY 6F DA guiding catheter involved the cervical ICA (79.6%), horizontal petrous ICA (17.3%), and vertical petrous ICA (3.1%). Final control angiograms after endovascular coiling showed proximal change in the final, compared to the initial, position of the ENVOY 6F DA guiding catheter in 25 cases (25.51%). Procedure-related complications were observed in nine patients (9.18%), involving vasospasm in all cases; however, there was no symptomatic case.CONCLUSION: The ENVOY 6F DA guiding catheter had relatively sufficient distal navigability without symptomatic procedural complications. However, the change in the catheter position after endovascular coiling denoted insufficient supportability.
Aneurysm
;
Carotid Arteries
;
Carotid Artery, Internal
;
Catheterization
;
Catheters
;
Cerebrovascular Circulation
;
Demography
;
Embolization, Therapeutic
;
Female
;
Humans
;
Intracranial Aneurysm
8.Infliximab Treatment for Intravenous Immunoglobulin-resistant Kawasaki Disease: a Multicenter Study in Korea
Gyu HUR ; Min Seob SONG ; Sejung SOHN ; Hyoung Doo LEE ; Gi Beom KIM ; Hwa Jin CHO ; Kyung Lim YOON ; Chan Uhng JOO ; Myung Chul HYUN ; Chul Ho KIM
Korean Circulation Journal 2019;49(2):183-191
BACKGROUND AND OBJECTIVES:
We investigated the status of infliximab use in intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD) patients and the incidence of coronary artery aneurysms (CAAs) according to treatment regimens.
METHODS:
Between March 2010 and February 2017, 16 hospitals participated in this study. A total of 102 (32.3±19.9 months, 72 males) who received infliximab at any time after first IVIG treatment failure were enrolled. Data were retrospectively collected using a questionnaire.
RESULTS:
Subjects were divided into two groups according to the timing of infliximab administration. Early treatment (group 1) had shorter fever duration (10.5±4.4 days) until infliximab infusion than that in late treatment (group 2) (16.4±4.5 days; p < 0.001). We investigated the response rate to infliximab and the incidence of significant CAA (z-score >5). Overall response rate to infliximab was 89/102 (87.3%) and the incidence of significant CAA was lower in group 1 than in group 2 (1/42 [2.4%] vs. 17/60 [28.3%], p < 0.001).
CONCLUSIONS
This study suggests that the early administration of infliximab may reduce the incidence of significant CAA in patients with IVIG-resistant KD. However, further prospective randomized studies with larger sample sizes are required.
9.Infliximab Treatment for Intravenous Immunoglobulin-resistant Kawasaki Disease: a Multicenter Study in Korea
Gyu HUR ; Min Seob SONG ; Sejung SOHN ; Hyoung Doo LEE ; Gi Beom KIM ; Hwa Jin CHO ; Kyung Lim YOON ; Chan Uhng JOO ; Myung Chul HYUN ; Chul Ho KIM
Korean Circulation Journal 2019;49(2):183-191
BACKGROUND AND OBJECTIVES: We investigated the status of infliximab use in intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD) patients and the incidence of coronary artery aneurysms (CAAs) according to treatment regimens. METHODS: Between March 2010 and February 2017, 16 hospitals participated in this study. A total of 102 (32.3±19.9 months, 72 males) who received infliximab at any time after first IVIG treatment failure were enrolled. Data were retrospectively collected using a questionnaire. RESULTS: Subjects were divided into two groups according to the timing of infliximab administration. Early treatment (group 1) had shorter fever duration (10.5±4.4 days) until infliximab infusion than that in late treatment (group 2) (16.4±4.5 days; p < 0.001). We investigated the response rate to infliximab and the incidence of significant CAA (z-score >5). Overall response rate to infliximab was 89/102 (87.3%) and the incidence of significant CAA was lower in group 1 than in group 2 (1/42 [2.4%] vs. 17/60 [28.3%], p < 0.001). CONCLUSIONS: This study suggests that the early administration of infliximab may reduce the incidence of significant CAA in patients with IVIG-resistant KD. However, further prospective randomized studies with larger sample sizes are required.
Aneurysm
;
Coronary Vessels
;
Fever
;
Humans
;
Immunoglobulins
;
Immunoglobulins, Intravenous
;
Incidence
;
Infliximab
;
Korea
;
Mucocutaneous Lymph Node Syndrome
;
Prospective Studies
;
Retrospective Studies
;
Sample Size
;
Treatment Failure
10.Effect of Low - Dose Midazolam for Colonoscopy.
Hwa Young LEE ; Jae Jun KIM ; Young Ho KIM ; In Kyung SUNG ; Hee Jung SON ; Poong Lyul RHEE ; Kwang Cheol KOH ; Seung Woon PAIK ; Jong Chul RHEE
Korean Journal of Gastrointestinal Endoscopy 1998;18(4):499-505
BACKGROUND/AIMS: Because colonoscopy is a painful procedure, analgesics and sedatives may be necessary as premedication. Midazolam reacts quicker, has a more excellent amnesic effect and fewer complications compared to diazepam. The effects of midazolam depend on dose, age, and rapidity of injection. According to several studies, side effects of midazolam were more common in high-dose injections (more than 5 mg) compared to low dose injections (0.03-0.05 rng/kg). Moreover, low dose injections were found to be as effective as high dose injections. However, there was no report about the effect and the side effects of midazolam in Korea. Therefore, we performed this study to determine the effect of low dose midazolam as premedication for colonoscopy. METHODS: We performed colonoscopy in 99 consecutive patients who were randomly selected (midazolam group: 50, placebo group: 49) prospectively from July 1996 to September 1996. Premedication was administered through intravenous injection of midazolam or saline 0.03 mg/kg, combined with intramuscular injections of meperidine 50 mg, and intravenous injections of Buscopan 20 mg in all patients. Blood pressure, puise rate, and O2 saturation by oxymeter were checked before, during, and 30 minutes after colonoscopy. The degree of amnesia, discomfort, cooperation and acceptance of the re-examination were checked.
Amnesia
;
Analgesics
;
Blood Pressure
;
Butylscopolammonium Bromide
;
Colonoscopy*
;
Diazepam
;
Humans
;
Hypnotics and Sedatives
;
Injections, Intramuscular
;
Injections, Intravenous
;
Korea
;
Meperidine
;
Midazolam*
;
Premedication
;
Prospective Studies